Please use this identifier to cite or link to this item:
https://open.uns.ac.rs/handle/123456789/1250
DC Field | Value | Language |
---|---|---|
dc.contributor.author | Zoran Radovanović | en_US |
dc.contributor.author | Milan Ranisavljević | en_US |
dc.contributor.author | Dragana Radovanović | en_US |
dc.contributor.author | Ferenc Vicko | en_US |
dc.contributor.author | Tatjana Ivković Kapicl | en_US |
dc.contributor.author | Nenad Šolajić | en_US |
dc.date.accessioned | 2019-09-23T10:14:29Z | - |
dc.date.available | 2019-09-23T10:14:29Z | - |
dc.date.issued | 2018-10-01 | - |
dc.identifier.issn | 16613791 | en_US |
dc.identifier.uri | https://open.uns.ac.rs/handle/123456789/1250 | - |
dc.description.abstract | © 2018 S. Karger GmbH, Freiburg. Copyright: All rights reserved. Background: This study aimed to examine the incidence of surgical complications associated with nipple-sparing mastectomy (NSM) with primary implant reconstruction, analyze risk factors for early and late surgical complications of NSM, and determine the incidence of local recurrences and the safety of sparing the nipple-areola complex (NAC). Methods: This retrospective cohort study included 435 patients with 441 NSM procedures over a period of 9 years (2004-2012). All surgical complications and the oncological outcome were recorded during follow-up. Results: The most common early surgical complication was skin flap ischemia/necrosis (26 patients, 5.9%). Prosthesis explantation due to complications was carried out in 11 (2.5%) cases. Neoadjuvant chemotherapy, implant size >500 ml, diabetes mellitus, body mass index > 25 kg/m2, and incisions other than lateral were risk factors for early complications (p < 0.001). The NAC excision rate was 5.4% (24 cases) due to confirmed presence of cancer cells in the subareolar tissue. Capsular contracture as a late complication occurred in 33 (7.48%) cases. Local relapse occurred in 32 (7.3%) patients. Distant metastases were diagnosed in 68 (15.6%) patients, and 53 (12.2%) patients died during the follow-up period. Conclusions: NSM with immediate implant reconstruction has an acceptable morbidity rate and is an oncologically and surgically appropriate treatment for most women requiring mastectomy. | en_US |
dc.language.iso | en | en_US |
dc.relation.ispartof | Breast Care | en_US |
dc.subject | Breast cancer | en_US |
dc.subject | Nipple-sparing mastectomy | en_US |
dc.subject | Complications | en_US |
dc.subject | Oncological outcome | en_US |
dc.title | Nipple-Sparing Mastectomy with Primary Implant Reconstruction: Surgical and Oncological Outcome of 435 Breast Cancer Patients | en_US |
dc.type | Journal/Magazine Article | en_US |
dc.identifier.doi | 10.1159/000489317 | - |
dc.identifier.scopus | 2-s2.0-85048853877 | - |
dc.identifier.url | https://api.elsevier.com/content/abstract/scopus_id/85048853877 | - |
dc.description.version | Published | en_US |
dc.relation.lastpage | 378 | en_US |
dc.relation.firstpage | 373 | en_US |
dc.relation.issue | 5 | en_US |
dc.relation.volume | 13 | en_US |
item.fulltext | No Fulltext | - |
item.grantfulltext | none | - |
crisitem.author.dept | Medicinski fakultet, Katedra za onkologiju | - |
crisitem.author.dept | Medicinski fakultet, Katedra za hirurgiju | - |
crisitem.author.dept | Medicinski fakultet, Katedra za anesteziju i perioperativnu medicinu | - |
crisitem.author.dept | Medicinski fakultet, Katedra za hirurgiju | - |
crisitem.author.dept | Medicinski fakultet, Katedra za patologiju | - |
crisitem.author.orcid | 0000-0003-4249-9260 | - |
crisitem.author.parentorg | Medicinski fakultet | - |
crisitem.author.parentorg | Medicinski fakultet | - |
crisitem.author.parentorg | Medicinski fakultet | - |
crisitem.author.parentorg | Medicinski fakultet | - |
crisitem.author.parentorg | Medicinski fakultet | - |
Appears in Collections: | MDF Publikacije/Publications |
SCOPUSTM
Citations
13
checked on May 3, 2024
Page view(s)
35
Last Week
14
14
Last month
2
2
checked on May 10, 2024
Google ScholarTM
Check
Altmetric
Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.